Myocarditis in the setting of recent COVID‐19 vaccination
L Onderko, B Starobin, AE Riviere… - Case Reports in …, 2021 - Wiley Online Library
We report three patients who presented with chest pain after receiving either the BNT162b2
Pfizer/BioNTech or mRNA‐1273 Moderna/NIH vaccine. Clinical presentation, biomarker …
Pfizer/BioNTech or mRNA‐1273 Moderna/NIH vaccine. Clinical presentation, biomarker …
Acute myocarditis after COVID-19 vaccination: a case report
P Schmitt, R Demoulin, R Poyet, E Capilla… - La Revue de medecine …, 2021 - Elsevier
Introduction The etiology of myocarditis often remains undetermined. A large variety of
infectious agents, systemic diseases, drugs, and toxins can cause the disease. We report the …
infectious agents, systemic diseases, drugs, and toxins can cause the disease. We report the …
Myocarditis following COVID-19 mRNA vaccination
Background Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety. We report
six cases of myocarditis, which occurred shortly after BNT162b2 vaccination. Methods …
six cases of myocarditis, which occurred shortly after BNT162b2 vaccination. Methods …
[HTML][HTML] Recurrent myocarditis following COVID-19 infection and the mRNA vaccine
COVID-19 infection has cardiovascular manifestations such as acute myocarditis,
arrhythmia, ischemic cardiomyopathy, heart failure, pericardial effusion, cardiac tamponade …
arrhythmia, ischemic cardiomyopathy, heart failure, pericardial effusion, cardiac tamponade …
Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines
DK Shay, TT Shimabukuro, F DeStefano - JAMA cardiology, 2021 - jamanetwork.com
Two reports in the current issue of JAMA Cardiology describe cases of acute myocarditis that
occurred among persons who received the BNT162b2-mRNA (Pfizer-BioNTech) or mRNA …
occurred among persons who received the BNT162b2-mRNA (Pfizer-BioNTech) or mRNA …
[PDF][PDF] A late presentation of COVID-19 vaccine-induced myocarditis
With the introduction of the coronavirus disease 2019 (COVID-19) mRNA vaccines, the
incidence of severe infection has significantly decreased. While the vaccines have been …
incidence of severe infection has significantly decreased. While the vaccines have been …
[HTML][HTML] Myocarditis after BNT162b2 and mRNA-1273 COVID-19 vaccination: A report of 7 cases
SK Ahmed - Annals of Medicine and Surgery, 2022 - Elsevier
Background and objectives According to some reports, there is a link between the
development of myocarditis and the administration of messenger RNA (mRNA) vaccines …
development of myocarditis and the administration of messenger RNA (mRNA) vaccines …
A report on short-term follow-up cardiac imaging and clinical outcomes of myocarditis after coronavirus disease 2019 vaccination
T Ahmed, E Chishti, GJ Sinner… - Journal of …, 2022 - journals.lww.com
Methods This is an observational case series of patients who were diagnosed with
myocarditis after mRNA COVID-19 vaccination. The clinical characteristics, short term (4–6 …
myocarditis after mRNA COVID-19 vaccination. The clinical characteristics, short term (4–6 …
Prognosis of myocarditis developing after mRNA COVID-19 vaccination compared with viral myocarditis
Background Association between messenger RNA (mRNA) COVID-19 vaccines and
myocarditis has aroused public concern over vaccine safety. Objectives The goal of this …
myocarditis has aroused public concern over vaccine safety. Objectives The goal of this …
[HTML][HTML] COVID-19 vaccine-associated myocarditis
MC Morgan, L Atri, S Harrell, W Al-Jaroudi… - World Journal of …, 2022 - ncbi.nlm.nih.gov
Myocarditis is now recognized as a rare complication of coronavirus disease 2019 (COVID-
19) mRNA vaccination, particularly in adolescent and young adult males. Since the …
19) mRNA vaccination, particularly in adolescent and young adult males. Since the …